bisoprolol has been researched along with Colonic Neoplasms in 1 studies
Bisoprolol: A cardioselective beta-1 adrenergic blocker. It is effective in the management of HYPERTENSION and ANGINA PECTORIS.
Colonic Neoplasms: Tumors or cancer of the COLON.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In patients undergoing colon cancer surgery, the risk of 90-day postoperative mortality does not differ between the investigated types of β-adrenergic blocking agents." | 1.72 | Pharmacological differences between beta-blockers and postoperative mortality following colon cancer surgery. ( Ahl Hulme, R; Bass, GA; Cao, Y; Ekestubbe, L; Forssten, MP; Matthiessen, P; Mohseni, S; Sjölin, G, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ekestubbe, L | 1 |
| Bass, GA | 1 |
| Forssten, MP | 1 |
| Sjölin, G | 1 |
| Cao, Y | 1 |
| Matthiessen, P | 1 |
| Ahl Hulme, R | 1 |
| Mohseni, S | 1 |
1 other study available for bisoprolol and Colonic Neoplasms
| Article | Year |
|---|---|
Pharmacological differences between beta-blockers and postoperative mortality following colon cancer surgery.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Bisoprolol; Colonic Neoplasms; Humans; Metoprolol; R | 2022 |